Cystoid macular edema following intravitreal chemotherapy treatment for retinoblastoma
- 7 July 2020
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (9) , e28348
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Integrated Treatment during the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic ChemoreductionOcular Oncology and Pathology, 2018
- Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seedsBritish Journal of Ophthalmology, 2018
- Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastomaBritish Journal of Ophthalmology, 2017
- Intravitreal Melphalan for Vitreous Seeds: Initial Experience in ChinaJournal of Ophthalmology, 2016
- Anterior Ocular Toxicity of Intravitreous Melphalan for RetinoblastomaJAMA Ophthalmology, 2015
- Local and Systemic Toxicity of Intravitreal Melphalan for Vitreous Seeding in RetinoblastomaOphthalmology, 2014
- Combined Intravitreal Melphalan and Topotecan for Refractory or Recurrent Vitreous Seeding From RetinoblastomaJAMA Ophthalmology, 2014
- Persistence of retinal function after intravitreal melphalan injection for retinoblastomaDocumenta Ophthalmologica, 2012
- Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From RetinoblastomaArchives of Ophthalmology (1950), 2012
- Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle trackBritish Journal of Ophthalmology, 2012